Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Multiple Myeloma × lenvatinib × 30 days × Clear all

Sponsor

Conditions

Endometrial Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Thyroid Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Cholangiocarcinoma 3 Uterine Cervical Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Biliary Tract Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Liver Neoplasms 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Differentiated Thyroid Cancer 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Carcinoma, Transitional Cell 1 Advanced Malignancies 1 Adenocarcinoma 1

Interventions

Dexamethasone 56 Lenalidomide 36 daratumumab 34 Bortezomib 26 pomalidomide 22 carfilzomib 20 Cyclophosphamide 20 Calcium Dobesilate 20 Biopsy 18 Specimen Handling 17 Magnetic Resonance Spectroscopy 15 talquetamab 14 fludarabine 13 iberdomide 11 dexamethasone acetate 9 dexamethasone 21-phosphate 9 auricularum 9 selinexor 8 isatuximab 8 trametinib 6 fludarabine phosphate 6 tocilizumab 4 dabrafenib 4 belantamab mafodotin 4 nirogacestat 3 elotuzumab 3 X-Rays 3 Whole-Body Irradiation 3 Sunitinib 3 Stem Cell Transplantation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡